✦ LIBER ✦

Results of a phase II HPV vaccine trial with life recombinant vaccinia virus TA-HPV™

✍ Scribed by AM Kaufmann; EM Rankin; H Sommer; V. Nuessler; A Schneider; M Adams; HC Kitchener; T Bauknecht; U Wagner; K Kroon; J Hickling; CM Boswell; S Stacey; P Stern; J Gillard; J Wanders; Jst J. Roberts; H Zwierzina

Book ID: 117657742
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 96 KB
Volume: 37
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(01)80371-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Vaccination with HPV16 peptides of patie

Vaccination with HPV16 peptides of patients with advanced cervical carcinoma: clinical evaluation of a phase I–II trial

✍ W.J. van Driel; M.E. Ressing; G.G. Kenter; R.M.P. Brandt; E.J.T. Krul; A.B. van 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 114 KB

Phase I/II trial of immunogenicity of a

Phase I/II trial of immunogenicity of a human papillomavirus (HPV) type 16 E7 protein–based vaccine in women with oncogenic HPV-positive cervical intraepithelial neoplasia

✍ Sophie Hallez; Philippe Simon; Frédéric Maudoux; Jean Doyen; Jean-Christophe Noë 📂 Article 📅 2004 🏛 Springer-Verlag 🌐 English ⚖ 357 KB

Results of a phase I trial of a recombin

Results of a phase I trial of a recombinant vaccinia virus that expresses carcinoembryonic antigen in patients with advanced colorectal cancer

✍ David McAneny; Christine A. Ryan; Robert M. Beazley; Howard L. Kaufman 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 679 KB

Results of a phase II randomized, double

Results of a phase II randomized, double-blind, placebo-controlled trial of Polyphenon E in women with persistent high-risk HPV infection and low-grade cervical intraepithelial neoplasia

✍ Garcia, Francisco A.R.; Cornelison, Terri; Nuño, Tomas; Greenspan, David L.; Byr 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 300 KB

Heterologous prime-boost immunotherapy o

Heterologous prime-boost immunotherapy of melanoma patients with Influenza virosomes, and recombinant Vaccinia virus encoding 5 melanoma epitopes and 3 co-stimulatory molecules. A multi-centre phase I/II open labeled clinical trial

✍ Michel Adamina; Walter P. Weber; Rachel Rosenthal; Reto Schumacher; Paul Zajac; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 433 KB